New drug NAV-240 put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug, NAV-240, in 24 healthy adults. Participants received multiple doses of either the drug or a placebo. The main goal was to see what side effects occurred and how the drug moved through the body. This study did not aim to trea…
Phase: PHASE1 • Sponsor: Navigator Medicines, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 07:07 UTC